Kalliopi Vrotsou1, Mónica Machón2, Francisco Rivas-Ruíz3, Estefanía Carrasco4, Eugenio Contreras-Fernández5, Maider Mateo-Abad6, Carolina Güell7, Itziar Vergara8. 1. Unidad de Investigación de Atención Primaria-OSIS Gipuzkoa, Osakidetza, Instituto de Investigación Sanitaria Biodonostia, San Sebastián, Spain; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Spain; Centro de Investigación en Cronicidad Kronikgune, Barakaldo, Spain. Electronic address: kalliopi.vrotsoukanari@osakidetza.eus. 2. Unidad de Investigación de Atención Primaria-OSIS Gipuzkoa, Osakidetza, Instituto de Investigación Sanitaria Biodonostia, San Sebastián, Spain; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Spain; Centro de Investigación en Cronicidad Kronikgune, Barakaldo, Spain. Electronic address: monica.machonsobrado@osakidetza.eus. 3. Unidad de Investigación, Hospital Costa del Sol, Marbella, Spain; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Spain. Electronic address: frivasr@hcs.es. 4. Grupo de Oncología Celular, Instituto de Investigación Sanitaria Biodonostia, San Sebastián, Spain; CIBER de Fragilidad y Envejecimiento Saludable (CIBERfes), Spain. Electronic address: estefania.carrasco@biodonostia.org. 5. Unidad Gestión Clínica de Prevención, Promoción y Vigilancia de la Salud, Distrito Sanitario Costa del Sol, Servicio Andaluz de Salud, Mijas, Málaga, Spain; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Spain. Electronic address: eugenio.contreras.sspa@juntadeandalucia.es. 6. Unidad de Investigación de Atención Primaria-OSIS Gipuzkoa, Osakidetza, Instituto de Investigación Sanitaria Biodonostia, San Sebastián, Spain; Centro de Investigación en Cronicidad Kronikgune, Barakaldo, Spain. Electronic address: maider.mateoabad@osakidetza.eus. 7. Unidad de Investigación de Atención Primaria-OSIS Gipuzkoa, Osakidetza, Instituto de Investigación Sanitaria Biodonostia, San Sebastián, Spain; Centro de Salud de Alza, OSI Donostialdea, Osakidetza, San Sebastián, Spain. Electronic address: carolina.guellpelayo@osakidetza.eus. 8. Unidad de Investigación de Atención Primaria-OSIS Gipuzkoa, Osakidetza, Instituto de Investigación Sanitaria Biodonostia, San Sebastián, Spain; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Spain; Centro de Investigación en Cronicidad Kronikgune, Barakaldo, Spain. Electronic address: mariaiciar.vergaramitxeltorena@osakidetza.eus.
Abstract
BACKGROUND: The Tilburg Frailty Indicator (TFI) is a 15-item scale. It diagnoses frailty in the elderly based on three domains: physical, psychological and social. A Spanish cross-cultural adaptation and its psychometric properties are presented here. MATERIALS AND METHODS: Independent, non-institutionalized ≥70 year-olds were recruited. The TFI structure was assessed with Kuder-Richardson (KR-20) and confirmatory factor analyses. Sperman´s correlations (rs) with Timed Up-and-Go, Self-assessed-health, Fried criteria, Short Physical Performance Battery, Gerontopole Frailty tool, assessed convergent validity. Known groups' validity and test-retest reliability were tested. RESULTS: Based on n = 856 participants, domain and total scale KR-20 were <0.70. The social domain and certain physical items did not fit adequately. Most physical and total scalers were 0.31-0.48. Social domain rs were <0.30. The TFI differentiated frail and no-frail subjects, but test-retest variation was considerable. DISCUSSION: TFI applicability at different social contexts and frailty stages are worth of additional study. Certain scale aspects should be reconsidered.
BACKGROUND: The Tilburg Frailty Indicator (TFI) is a 15-item scale. It diagnoses frailty in the elderly based on three domains: physical, psychological and social. A Spanish cross-cultural adaptation and its psychometric properties are presented here. MATERIALS AND METHODS: Independent, non-institutionalized ≥70 year-olds were recruited. The TFI structure was assessed with Kuder-Richardson (KR-20) and confirmatory factor analyses. Sperman´s correlations (rs) with Timed Up-and-Go, Self-assessed-health, Fried criteria, Short Physical Performance Battery, Gerontopole Frailty tool, assessed convergent validity. Known groups' validity and test-retest reliability were tested. RESULTS: Based on n = 856 participants, domain and total scale KR-20 were <0.70. The social domain and certain physical items did not fit adequately. Most physical and total scalers were 0.31-0.48. Social domain rs were <0.30. The TFI differentiated frail and no-frail subjects, but test-retest variation was considerable. DISCUSSION: TFI applicability at different social contexts and frailty stages are worth of additional study. Certain scale aspects should be reconsidered.
Authors: Jossiana Wilke Faller; David do Nascimento Pereira; Suzana de Souza; Fernando Kenji Nampo; Fabiana de Souza Orlandi; Silvia Matumoto Journal: PLoS One Date: 2019-04-29 Impact factor: 3.240
Authors: Itziar Vergara; Maider Mateo-Abad; María Carmen Saucedo-Figueredo; Mónica Machón; Alonso Montiel-Luque; Kalliopi Vrotsou; María Antonia Nava Del Val; Ana Díez-Ruiz; Carolina Güell; Ander Matheu; Antonio Bueno; Jazmina Núñez; Francisco Rivas-Ruiz Journal: BMC Geriatr Date: 2019-12-03 Impact factor: 3.921